https://www.ambergen.com/wp-content/uploads/logo-retina.png00Kenneth Rothschildhttps://www.ambergen.com/wp-content/uploads/logo-retina.pngKenneth Rothschild2012-02-27 13:46:482016-11-10 12:44:59AmberGen receives US Patent 8,114,587 for analyzing DNA mutations in fecal samples for colorectal cancer detection
